Enhanced antitumor efficacy and attenuated cardiotoxicity of doxorubicin in combination with lycopene liposomes

A novel formulation of [6]-gingerol: Proliposomes with enhanced oral bioavailability and antitumor effect

(2018) Qilong Wang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

In vitro effects and mechanisms of lycopene in MCF-7 human breast cancer cells

(2017) S.J. Peng et al.   GENETICS AND MOLECULAR RESEARCH

Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer

(2017) Chunlai Feng et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery

(2017) Weikun Li et al.   JOURNAL OF CONTROLLED RELEASE

Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model

(2016) Mohammed-Salleh M. Ardawi et al.   BONE

Enhanced cytotoxic and apoptosis inducing activity of lycopene oxidation products in different cancer cell lines

(2016) Bangalore Prabhashankar Arathi et al.   FOOD AND CHEMICAL TOXICOLOGY

Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study II Nutrition Cohort

(2016) Ying Wang et al.   INTERNATIONAL JOURNAL OF CANCER

TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluationin vitroandin vivo

(2016) Lei Yang et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice

(2016) Bidya Dhar Sahu et al.   LIFE SCIENCES

Radix Astragali and Tanshinone Help Carboplatin Inhibit B16 Tumor Cell Growth

(2016) Jinyi Wu et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Paeonol inhibits B16F10 melanoma metastasisIn vitroandIn Vivovia disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways

(2015) Lei Zhang et al.   IUBMB LIFE

Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma

(2015) Jinfang Zhu et al.   Journal of Biomedical Nanotechnology

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer

(2014) Sergio Granados-Principal et al.   BIOCHEMICAL PHARMACOLOGY

Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells

(2014) Yukihiko Kato et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin

(2014) Nitin K. Swarnakar et al.   Nanomedicine-Nanotechnology Biology and Medicine

Application of liposomes in drug development – focus on gastroenterological targets

(2013) Jian-xin Zhang et al.   International Journal of Nanomedicine

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo

(2011) Chang Chu et al.   ACTA PHARMACOLOGICA SINICA

Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport

(2010) Waleed Faisal et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY